Welcome to free breakfast seminar 23rd November 8:30-9:30am

For companies developing orphan products it’s key to have a strategy to handle regulatory differences and rewards that exists.

Join us to hear Thomas Lönngren, Strategic Advisor NDA Group and former Head of the European Medicine Agency EMA speak on the challenges and opportunities when handling orphan drug designations in EU and US and what this means for you.


  • Get the latest info on EU and US regulations
  • Identify the differences and similarities for the EU and US regulations
  • Learn how to overcome regulatory obstacles and hurdles
  • Hear how NDA can support you

When: Wednesday 23rd November 2016, 8:30-9:30am. Breakfast is served from 8:00am

Where: NDA Regulatory Service AB, Oxfordhuset, Johanneslundsvägen 2, Upplands Väsby

The breakfast seminar will be an open and interactive workshop with the opportunity to ask questions to Thomas and to the rest of the NDA team. Specific questions can also be sent in advance to frukostseminarium@ndareg.com
Indicate if you would like to discuss them openly during the meeting; otherwise we can book separate meetings to discuss them after the seminar.

Registration: RSVP by Wednesday 9th November 2016 to frukostseminarium@ndareg.com
The number of participants is limited and we can only accept two participants per company.

Contact: Lina Jansson, Marketing Associate, +46 (0)8 590 778 00, or email frukostseminarium@ndareg.com

The breakfast seminar is free. If you are unable to attend, please advise us no later than two days before the seminar.






Thomas Lönngren

Strategic Advisor

Read more

Stay up to date

Contact us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World

  • This field is for validation purposes and should be left unchanged.